Gyon Technologies Capital Management, LP Mirati Therapeutics, Inc. Transaction History

Gyon Technologies Capital Management, LP

  • $0
  • Q4 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$41.27 - $98.62 $189,057 - $451,778
4,581 New
4,581 $207,000
Q2 2021

Aug 16, 2021
SELL
$144.0 - $179.73 $437,040 - $545,480
-3,035 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$158.92 - $221.61 $482,322 - $672,586
3,035 New
3,035 $520,000

Others Institutions Holding MRTX

# of Institutions
16
Shares Held
3.57M
Call Options Held
0
Put Options Held
36.6K
View Full List

About Mirati Therapeutics, Inc.

MRTX Quotes by TradingView
  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Gyon Technologies Capital Management, LP Portfolio

Follow Gyon Technologies Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email